U.S. Food and Drug Administration

 FDA News Release,  Sep 5, 2001

Global Enterprises Recalls T³.

For Immediate Release

College Station, Texas, September 5, 2001 -- Global Enterprises is recalling T³, a dietary supplement, because it contains tiratricol, also known as triiodothyroacetic acid or TRIAC, a potent thyroid hormone that may cause serious health consequences including heart attacks and strokes.

The T³ was distributed nationwide to retail stores and sold via mail order. T³ is packaged in 90-count capsules in white bottles with black labels. All lot numbers are affected by this recall.

No illnesses have been reported to date from T³. This recall is being conducted with full knowledge of the U.S. Food and Drug Administration.

Global Enterprises urges all individuals who may have purchased this product, or any product containing tiratricol, to stop using them immediately and, in addition, to consult their health professional if they are experiencing any adverse effects, which may include insomnia, nervousness, sweating, and diarrhea.

Consumers who have purchased this product are urged to return it to the place of purchase for a full refund. Consumers with questions may contact Global Enterprises at 979-218-5935

The FDA posts press releases and other notices of recalls from the firms involved as a service to consumers, the media, and other interested parties. The FDA does not endorse either the product or the company.

The text in this article was prepared by the FDA Office of Public Affairs.